Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 23864222)

1.

Atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms.

Niedra E, Chahal N, Manlhiot C, Yeung RS, McCrindle BW.

Pediatr Cardiol. 2014 Jan;35(1):89-92. doi: 10.1007/s00246-013-0746-9. Epub 2013 Jul 18.

PMID:
23864222
2.

Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK; Treating to New Targets (TNT) Investigators.

N Engl J Med. 2005 Apr 7;352(14):1425-35. Epub 2005 Mar 8.

3.

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN; REVERSAL Investigators.

JAMA. 2004 Mar 3;291(9):1071-80.

PMID:
14996776
4.

Efficacy of alternate-day dosing versus daily dosing of atorvastatin.

Jafari M, Ebrahimi R, Ahmadi-Kashani M, Balian H, Bashir M.

J Cardiovasc Pharmacol Ther. 2003 Jun;8(2):123-6.

PMID:
12808485
5.

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J; CAP Investigators.

Clin Ther. 2008 Dec;30(12):2298-313. doi: 10.1016/j.clinthera.2008.12.023.

PMID:
19167589
6.
7.

Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease.

Dorval JF, Anderson T, Buithieu J, Chan S, Hutchison S, Huynh T, Jobin J, Lonn E, Poirier P, Title L, Walling A, Tran T, Boudreau G, Charbonneau F, Genest J.

Am J Cardiol. 2005 Jan 15;95(2):249-53.

PMID:
15642561
8.
9.

Comment on atorvastatin safety in kawasaki disease patients with coronary artery aneurysms.

Tremoulet AH.

Pediatr Cardiol. 2014 Jan;35(1):93. doi: 10.1007/s00246-013-0805-2. Epub 2013 Sep 27. No abstract available.

PMID:
24072043
10.
11.

Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?

Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U.

J Am Coll Cardiol. 2007 Mar 13;49(10):1035-42. Epub 2007 Feb 23.

12.

Author reply to comment on "atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms".

Manlhiot C, McCrindle BW.

Pediatr Cardiol. 2014 Jan;35(1):94-5. doi: 10.1007/s00246-013-0806-1. Epub 2013 Oct 15. No abstract available.

PMID:
24126955
13.
14.

A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD.

Harris KP, Wheeler DC, Chong CC; Atorvastatin in CAPD Study Investigators. Continuous ambulatory peritoneal dialysis.

Kidney Int. 2002 Apr;61(4):1469-74.

15.
16.

The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.

Blankier S, McCrindle BW, Ito S, Yeung RS.

Clin Exp Immunol. 2011 May;164(2):193-201. doi: 10.1111/j.1365-2249.2011.04331.x. Epub 2011 Mar 1.

17.

Effect of two intensive statin regimens on progression of coronary disease.

Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, Raichlen JS, Uno K, Borgman M, Wolski K, Nissen SE.

N Engl J Med. 2011 Dec 1;365(22):2078-87. doi: 10.1056/NEJMoa1110874. Epub 2011 Nov 15.

19.

An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia.

Gandelman K, Glue P, Laskey R, Jones J, LaBadie R, Ose L.

Pediatr Cardiol. 2011 Apr;32(4):433-41. doi: 10.1007/s00246-011-9885-z. Epub 2011 Jan 23.

20.

Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators.

N Engl J Med. 2004 Apr 8;350(15):1495-504. Epub 2004 Mar 8. Erratum in: N Engl J Med. 2006 Feb 16;354(7):778.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk